Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
Merck
Federal Trade Commission
McKesson
Johnson and Johnson
Cerilliant
QuintilesIMS
AstraZeneca
Fish and Richardson

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017029

« Back to Dashboard

NDA 017029 describes HEPARIN SODIUM PRESERVATIVE FREE, which is a drug marketed by Fresenius Kabi Usa, Hospira, Pfizer, Pharma Serve Ny, Sagent Pharms, Shenzhen Techdow, and Watson Labs Inc, and is included in eight NDAs. It is available from seven suppliers. Additional details are available on the HEPARIN SODIUM PRESERVATIVE FREE profile page.

The generic ingredient in HEPARIN SODIUM PRESERVATIVE FREE is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 017029
Tradename:HEPARIN SODIUM PRESERVATIVE FREE
Applicant:Fresenius Kabi Usa
Ingredient:heparin sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 017029
Ingredient-typeHeparin
Suppliers and Packaging for NDA: 017029
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017029 NDA General Injectables & Vaccines, Inc 52584-542 52584-542-01 1 VIAL, MULTI-DOSE in 1 BAG (52584-542-01) > 1 mL in 1 VIAL, MULTI-DOSE
HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017029 NDA Cardinal Health 55154-9354 55154-9354-5 5 VIAL in 1 BAG (55154-9354-5) > 1 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength5,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Teva
Cantor Fitzgerald
Harvard Business School
Julphar
UBS
Cipla
Daiichi Sankyo
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot